Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2016

Dec 27, 2016

35081_dirs_2016-12-27_181eb1db-f039-492f-b83d-f0631efd4c5b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2016-11-01

Reporting Person: STERTZER SIMON H (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-01 Common Stock P 100000 $0.1641 Acquired 4816171 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30956710 Indirect
Common Stock 1258925 Indirect
Common Stock 5386743 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $0.1620 to $0.1650 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

F2: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers.

F3: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

F4: These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.

F5: These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.